Therapeutic effect of cilastatin administration in LPS-induced retinotoxicity
| dc.contributor.author | San Felipe Riba, Diego | |
| dc.contributor.author | Martín Sanchez, Beatriz | |
| dc.contributor.author | González Nicolás, María | |
| dc.contributor.author | Llorente Miguel, Ricardo | |
| dc.contributor.author | Marco López, Eva María | |
| dc.contributor.author | López Gallardo, Meritxell | |
| dc.contributor.author | Lázaro, Alberto | |
| dc.date.accessioned | 2026-06-12T16:27:34Z | |
| dc.date.available | 2026-06-12T16:27:34Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Sepsis is a life-threatening condition characterized by a dysregulated host response to infection that leads to multi-organ dysfunction. While its impact on the central nervous system is increasingly recognized, its effects on the retina require further study. Herein, this study aims to determine if systemic LPS‑induced sepsis causes retinal damage and whether cilastatin (CIL) may attenuate this injury. | en |
| dc.description.filiation | UEM | |
| dc.description.impact | 7.5 Q1 JCR 2025 | |
| dc.description.impact | 2.074 Q1 SJR 2025 | |
| dc.description.impact | No data IDR 2024 | |
| dc.description.sponsorship | Instituto de Salud Carlos III-Fondo de Investigación en Salud (PI20/01577) | es |
| dc.description.sponsorship | ISCIII-RICORS2040 (RD21/0005/0029) | es |
| dc.description.sponsorship | RICORS2040-Renal (RD24/0004/0023) | es |
| dc.description.sponsorship | 2022/BMD-7223 | es |
| dc.description.sponsorship | CPP2022–009633 | es |
| dc.identifier.citation | San Felipe, D., Martín-Sánchez, B., González-Nicolás, M. A., Llorente, R., Marco, E. M., López-Gallardo, M., & Lázaro, A. (2026). Therapeutic effect of cilastatin administration in LPS-induced retinotoxicity. Biomedicine & Pharmacotherapy, 200, 119557. https://doi.org/10.1016/j.biopha.2026.119557 | |
| dc.identifier.doi | 10.1016/j.biopha.2026.119557 | |
| dc.identifier.issn | 0753-3322 | |
| dc.identifier.issn | 1950-6007 | |
| dc.identifier.uri | https://hdl.handle.net/11268/17159 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1016/j.biopha.2026.119557 | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.other | Biociencias | |
| dc.subject.other | Lipopolisacáridos | |
| dc.subject.other | Células ganglionares de la retina | |
| dc.subject.other | Enfermedades neuroinflamatorias | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Enfermedad del sistema nervioso | |
| dc.subject.unesco | Investigación médica | |
| dc.subject.unesco | Medicina preventiva | |
| dc.title | Therapeutic effect of cilastatin administration in LPS-induced retinotoxicity | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1

